![]() Pfizer retained the rights to sell OTC Zantac domestically and retained ownership over the Zantac trademark after the joint partnership with GSK concluded in 1998. Pfizer Inc.: In 1993, Pfizer entered into a joint venture with Glaxo to develop an over the counter (OTC) Zantac, which became available in 1996.GSK controlled the New Drug Application (NDA) for prescription Zantac between 19. GSK received approval to market prescription Zantac in 1983 and it quickly became one of the company’s most successful products. GlaxoSmithKline LLC (GSK): The original developer of Zantac ( ranitidine). ![]() The Zantac lawsuits in Delaware are against the following defendants: Plaintiffs in the litigation ingested Zantac and developed the following cancers: More than 77,000 people from across the nation have cases filed in Delaware state court and allege in lawsuits that Zantac contains a known carcinogen called N-nitrosodimethylamine (NDMA). It’s time for them to take responsibility for the harm they have caused.” “They should have warned about the risks but, sensing the potential for a billion dollar blockbuster drug, the company chose profits over people. “GSK’s own scientists knew the risks Zantac posed to the public even before the FDA approved the drug,” says attorney Jennifer A. “We look forward to presenting evidence at trial that Zantac causes cancer, and that the defendants have known about the risks for decades.” “The formation of a new venue for these cases creates more opportunity for our clients and other people throughout the country stricken with cancer after taking a drug that we believe is dangerous,” says attorney R. ![]() Wisner and Moore also co-lead the Zantac Judicial Council Coordinated Proceedings (JCCP) in California, overseeing more than 5,000 cases pending there. Moore (Moore Law Group), Raeann Warner (Jacobs & Crumplar), and Justin Parafinczuk (Parafinczuk Wolf) in the plaintiffs’ leadership, which is responsible for presenting the plaintiffs’ position in all pretrial matters, initiating and coordinating pretrial discovery, and more. Medinilla named Wisner and three other lawyers to the leadership position in a Case Management Order that applies to all personal injury and wrongful death cases currently pending in the Superior Court of the State of Delaware that involve the use of prescription or over-the-counter Zantac (or any ranitidine-containing product). N22C-09-101 ZAN) in Delaware Superior Court. Brent Wisner will be co-lead trial counsel in the Zantac (Ranitidine) Products Liability litigation (Civil Action No. WILMINGTON, DELAWARE – - Wisner Baum managing partner and senior trial attorney R.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |